TaiMed Biologics Inc. (TPEX: 4147)
Taiwan
· Delayed Price · Currency is TWD
86.00
+0.50 (0.58%)
Dec 31, 2024, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 24.11 billion as of January 3, 2025. Its market cap has increased by 14.14% in one year.
Market Cap
24.11B
Enterprise Value
22.47B
Revenue
622.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
86.00
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 24.11B, an increase of 834.45%. That is a compound annual growth rate of 16.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 205.06B |
Caliway Biopharmaceuticals | 90.07B |
Bora Pharmaceuticals Co., LTD. | 77.20B |
Lotus Pharmaceutical | 70.20B |
Oneness Biotech | 40.01B |
Lumosa Therapeutics | 39.86B |
Polaris Group | 34.14B |
Center Laboratories | 31.01B |